Pulmoner Emboli
Synopsis
Pulmonary embolism (PE) is an urgent and serious cardiovascular condition resulting from the occlusion of the pulmonary artery or its branches, mostly caused by a thrombus originating from deep vein thrombosis (DVT) in the lower extremities. Within the framework of Virchow's triad, venous stasis, hypercoagulability, and endothelial injury constitute the fundamental etiologic mechanisms of the disease. In addition to genetic thrombophilias, acquired factors such as prolonged immobilization, recent surgery, obesity, pregnancy, malignancy, and infection are significant risk factors for PE development. Clinically, PE is classified into hemodynamically unstable (high-risk), which leads to hypotension and obstructive shock, and hemodynamically stable forms. The most common symptoms in patients include acute dyspnea, pleuritic chest pain, cough, hemoptysis, and syncope, while physical examination is highlighted by tachypnea and tachycardia. During the diagnostic evaluation, Wells and Geneva clinical prediction rules, alongside the D-dimer test, play a critical role in establishing clinical probability. For definitive diagnosis, multidetector computed tomography pulmonary angiography (CTPA) is the preferred initial imaging method, whereas lung V/Q scintigraphy is utilized when CTPA is contraindicated. While parenteral or oral anticoagulation (LMWH, UFH, NOAC) forms the main component of treatment, primary reperfusion strategies such as thrombolytic therapy, catheter-directed embolectomy, or surgical intervention are administered in high-risk patients with hemodynamic instability. Early and 30-day mortality risk stratification is carried out using the Pulmonary Embolism Severity Index (PESI or simplified sPESI) scores.
References
Rini BI, Wilding G, Hudes G, et al.: Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma. Journal of Clinical Oncology 27:4462-8, 2009
Rogers MA, Levine DA, Blumberg N, et al.: Triggers of hospitalization for venous thromboembolism. Circulation 125:2092-9, 2012
Blom JW, Doggen CJ, Osanto S, et al.: Malignancies, prothrombotic mutations, and the risk of venous thrombosis. Jama 293:715-22, 2005
Clayton TC, Gaskin M, Meade TW: Recent respiratory infection and risk of venous thromboembolism: case–control study through a general practice database. International journal of epidemiology 40:819-27, 2011
Prandoni P, Pesavento R, Sørensen HT, et al.: Prevalence of heart diseases in patients with pulmonary embolism with and without peripheral venous thrombosis: findings from a cross-sectional survey. European journal of internal medicine 20:470-3, 2009
Toft H, Horvath-Puho E, Pedersen L, et al.: Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. The Lancet 370:1773-9, 2007
Wendelboe AM, Raskob GE: Global burden of thrombosis: epidemiologic aspects. Circulation research 118:1340-7, 2016
Raskob GE, Angchaisuksiri P, Blanco AN, et al.: Thrombosis: a major contributor to global disease burden. Arteriosclerosis, thrombosis, and vascular biology 34:2363-71, 2014
Horlander KT, Mannino DM, Leeper KV: Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Archives of internal medicine 163:1711-7, 2003
Moser KM: Venous Thrornboembollsm'. Am Rev Respir Dis 141:235-49, 1990
Nakos G, Kitsiouli EI, Lekka ME: Bronchoalveolar lavage alterations in pulmonary embolism. American journal of respiratory and critical care medicine 158:1504-10, 1998
Morrone D, Morrone V: Acute pulmonary embolism: focus on the clinical picture. Korean circulation journal 48:365, 2018
Stein PD, Henry JW: Clinical characteristics of patients with acute pulmonary embolism stratified according to their presenting syndromes. Chest 112:974-9, 1997
Stein PD, Beemath A, Matta F, et al.: Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II. The American journal of medicine 120:871-9, 2007
Barco S, Ende-Verhaar YM, Becattini C, et al.: Differential impact of syncope on the prognosis of patients with acute pulmonary embolism: a systematic review and meta-analysis. European heart journal 39:4186-95, 2018
Courtney DM, Sasser HC, Pincus CL, et al.: Pulseless electrical activity with witnessed arrest as a predictor of sudden death from massive pulmonary embolism in outpatients. Resuscitation 49:265-72, 2001
Kucher N, Goldhaber SZ: Management of massive pulmonary embolism. Circulation 112:e28-e32, 2005
Kiely DG, Kennedy NS, Pirzada O, et al.: Elevated levels of natriuretic peptides in patients with pulmonary thromboembolism. Respiratory medicine 99:1286-91, 2005
Henzler T, Roeger S, Meyer M, et al.: Pulmonary embolism: CT signs and cardiac biomarkers for predicting right ventricular dysfunction. European Respiratory Journal 39:919-26, 2012
Meyer T, Binder L, Hruska N, et al.: Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. Journal of the American College of Cardiology 36:1632-6, 2000
Konstantinides S, Geibel A, Olschewski M, et al.: Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 106:1263-8, 2002
Horlander KT, Leeper KV: Troponin levels as a guide to treatment of pulmonary embolism. Current opinion in pulmonary medicine 9:374-7, 2003
Rodger M, Makropoulos D, Turek M, et al.: Diagnostic value of the electrocardiogram in suspected pulmonary embolism. American Journal of Cardiology 86:807-9, 2000
Worsley DF, Alavi A, Aronchick J, et al.: Chest radiographic findings in patients with acute pulmonary embolism: observations from the PIOPED Study. Radiology 189:133-6, 1993
Ghaye B, Szapiro D, Mastora I, et al.: Peripheral pulmonary arteries: how far in the lung does multi-detector row spiral CT allow analysis? Radiology 219:629-36, 2001
Stein PD, Fowler SE, Goodman LR, et al.: Multidetector computed tomography for acute pulmonary embolism. New England Journal of Medicine 354:2317-27, 2006
Reid JH, Coche EE, Inoue T, et al.: Is the lung scan alive and well? Facts and controversies in defining the role of lung scintigraphy for the diagnosis of pulmonary embolism in the era of MDCT. European journal of nuclear medicine and molecular imaging 36:505-21, 2009
Investigators P: Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). Jama 263:2753-9, 1990
Wittram C, Waltman AC, Shepard J-AO, et al.: Discordance between CT and angiography in the PIOPED II study. Radiology 244:883-9, 2007
Stein P, Chenevert T, Fowler S, et al.: PIOPED III (Prospective Investigation of Pulmonary Embolism Diagnosis III) Investigators. Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med 152:434-43, 2010
Kearon C, Ginsberg JS, Hirsh J: The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Annals of internal medicine 129:1044-9, 1998
Le Gal G, Righini M, Sanchez O, et al.: A positive compression ultrasonography of the lower limb veins is highly predictive of pulmonary embolism on computed tomography in suspected patients. THROMBOSIS AND HAEMOSTASIS-STUTTGART- 95:963, 2006
Kline J, Mitchell A, Kabrhel C, et al.: Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism. Journal of Thrombosis and Haemostasis 2:1247-55, 2004
Coutance G, Cauderlier E, Ehtisham J, et al.: The prognostic value of markers of right ventricular dysfunction in pulmonary embolism: a meta-analysis. Critical care 15:R103, 2011
Hugli O, Righini M, Le Gal G, et al.: The pulmonary embolism rule‐out criteria (PERC) rule does not safely exclude pulmonary embolism. Journal of thrombosis and haemostasis 9:300-4, 2011
Stein PD, Hull RD, Matta F, et al.: Incidence of thrombocytopenia in hospitalized patients with venous thromboembolism. The American journal of medicine 122:919-30, 2009
Cossette B, Pelletier M-È, Carrier N, et al.: Evaluation of bleeding risk in patients exposed to therapeutic unfractionated or low-molecular weight heparin: a cohort study in the context of a quality improvement initiative. Annals of Pharmacotherapy 44:994-1002, 2010
Goldhaber SZ, Come P, Lee R, et al.: Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. The Lancet 341:507-11, 1993
Daniels LB, Parker JA, Patel SR, et al.: Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism. The American journal of cardiology 80:184-8, 1997
Tafur AJ, Shamoun FE, Patel SI, et al.: Catheter-directed treatment of pulmonary embolism: a systematic review and meta-analysis of modern literature. Clinical and Applied Thrombosis/Hemostasis 23:821-9, 2017
Pasrija C, Kronfli A, Rouse M, et al.: Outcomes after surgical pulmonary embolectomy for acute submassive and massive pulmonary embolism: a single-center experience. The Journal of thoracic and cardiovascular surgery 155:1095-106. e2, 2018
Boutitie F, Pinede L, Schulman S, et al.: Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants’ data from seven trials. Bmj 342, 2011
Aujesky D, Obrosky DS, Stone RA, et al.: Derivation and validation of a prognostic model for pulmonary embolism. American journal of respiratory and critical care medicine 172:1041-6, 2005
Jiménez D, Aujesky D, Moores L, et al.: Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Archives of internal medicine 170:1383-9, 2010